What a development fee is
A development fee is the charge for creating a custom formula to a founder's specification. It applies to custom formulation only: with a stock formula, development is already done, and the founder is paying mainly for product, packaging, and labels. With custom work, no finished formula exists yet, and the fee funds the process of making one. The published band for that work is development at $2,000–$15,000+ per formula (estimate based on general industry patterns — not a quote), for custom formulas only. The band is wide because formulas vary widely in complexity, and because the work involved varies with the brief.
The fee is best understood as funding a process, not buying a product. The process starts with a brief — product type and format, packaging preferences, and the audience the product serves — and moves through trial batches, evaluation, and revision until a formula is ready for production. Each stage consumes skilled time and materials, and each stage produces something the founder must judge: a trial batch that is closer to the brief, or one that shows what still needs to change. That is the work described in formula and development fees in the skincare line cost guide, and the fee is the price of that work, stated separately from the price of making units.
Founders sometimes ask why a fee is needed at all when the production run will also be charged. The answer lies in the order of work. Production pricing covers making units of a finished formula. Development pricing covers reaching a finished formula in the first place. Without the development stage, there is nothing to produce; without the production stage, the developed formula never reaches buyers. The two stages are distinct kinds of work, with distinct costs, and the fee keeps them distinct so the founder can see what each stage costs and judge each on its own terms.
The anatomy of the fee
A development fee breaks into three parts, and each part deserves to be understood on its own. The parts are not separate charges in every quote — many manufacturers state a single fee — but asking what sits inside the fee, and how each part is handled, is how a founder judges whether the fee is complete. The three parts are chemist time, raw materials for trial batches, and revision rounds. Together they explain why the fee exists and why it varies.
Chemist time
The largest part of the fee, in most cases, is skilled time. A chemist takes the founder's brief and translates it into a working formula: choosing ingredients and proportions, considering how the formula will behave in its container and over its shelf life, and adjusting the balance as trial results come in. That translation is skilled work, not guesswork, and it draws on knowledge the founder is hiring rather than supplying. The fee therefore covers judgement as well as labour: the ability to read a trial batch, diagnose what is working and what is not, and decide what to change next. A brief that is clear and specific makes that time more effective, because the chemist starts from direction rather than from vagueness.
Raw materials for trial batches
Trial batches consume real materials. Each batch, however small, uses ingredients that must be sourced, measured, and combined, and each batch that does not meet the brief consumes materials without producing a saleable unit. Those materials are a genuine cost of development, and they are part of what the fee covers. The cost varies with the formula: ingredients, proportions, and the number of batches needed all affect how much material the development process consumes. A founder should not be surprised that materials appear inside the fee; the surprise would be a development process that consumed nothing, which would mean no trials had actually taken place.
Revision rounds
Revision rounds are the iterative heart of development. A first trial batch almost never ships unchanged, as a general observation in the cost guide notes, so the fee must allow for rounds of evaluation and adjustment. In each round, the founder evaluates a trial batch against the brief, gives clear feedback on what should change, and the chemist adjusts the formula and produces a further batch. The number of rounds a fee includes, and what counts as a revision within the fee, varies by manufacturer and must be confirmed in writing. Clear founder feedback makes rounds count: vague feedback wastes a round, while specific feedback — what is too heavy, too light, too strong, or too weak in feel or function — gives the next round direction.
Ask what a round means before you agree. Confirm how many revision rounds the fee includes, what counts as a revision, and what triggers a further charge, so the development scope is settled before work begins.
Why the fee is billed separately
Development is usually billed separately from production for a practical reason: the two stages happen at different times, involve different work, and carry different risks. Development money is committed before production money, and it is committed before the founder knows whether the formula will meet the brief in an acceptable number of rounds. Keeping the fee separate lets the founder see that commitment clearly, rather than having it absorbed into a production total where it would be harder to judge. Separation also keeps the production quote honest: the production price can be judged as the price of making units, without development work hidden inside it.
Separation protects both sides of the conversation. For the founder, it makes the development scope visible and negotiable: the fee can be discussed, the rounds it includes can be confirmed, and the point at which further charges would arise can be named. For the manufacturer, it makes the development work fundable on its own terms, without depending on a production run that has not yet been agreed. The founder should therefore expect a separate development line in a custom quote, and should treat its absence as a question to ask, not as a saving to celebrate. A custom quote without a visible development line may simply have the work priced elsewhere, and the founder is entitled to know where.
The timing of the separate billing also matters for cash planning. Development is funded first, and production is funded after the formula is approved, so the founder's money leaves in stages rather than in a single commitment. That staging is helpful, because it lets the founder judge the developed formula before committing production funds. It also means the founder must hold development funds ready at the start of the custom process, not only production funds at the end of it. Planning for both stages, in order, is part of planning a custom launch honestly.
What the fee does not cover
A development fee covers the work of creating the formula. It does not, on its own, cover the work of producing, packing, labelling, and testing units of that formula for sale. Those lines belong to the production stage and to the testing stage, and each must be confirmed separately in a quote. A founder who assumes the development fee covers everything will under-budget the launch; a founder who asks what each stage covers will budget each stage on its own terms. The distinction is the same one that makes separate billing useful, applied to the whole launch.
- Production fill and packaging. Making units of the finished formula, filling containers, and supplying packaging are production lines, charged on the production run rather than inside the development fee.
- Labels and printing. Printed labels, application, and any outer cartons or inserts are separate production lines, and each variant generally needs its own label handling.
- Testing. Whether testing is included in a quoted price or billed separately varies by manufacturer, so the test list and its billing must be confirmed in writing rather than assumed.
- Samples for evaluation beyond development. Trial batches inside development serve the formula; samples for the founder's own evaluation and for seeding to others are a separate planning matter with separate handling.
None of those lines is hidden by a clear quote. A clear quote itemises each bucket, states what the development fee covers, and names what is billed separately. The founder's task is to ask for that clarity and to read the quote bucket by bucket, rather than accepting a single total and hoping the missing lines are inside it. The development fee, understood as one bucket among several, becomes manageable. Misunderstood as the whole custom cost, it becomes a trap.
How to compare development fees
Comparing development fees means comparing scopes, not just figures. A lower fee that includes fewer revision rounds, or that leaves materials or rework to be charged separately, may cost more in total than a higher fee that includes a fuller scope. The founder should therefore compare fees on the same brief, with the same questions asked of each manufacturer: what the fee covers, how revision rounds are defined and counted, what triggers a further charge, and what happens if the formula does not meet the brief within the included rounds. Those answers, in writing, are what make two fees comparable. A figure without a scope is not a comparison; it is a guess.
For context on how the custom path differs from the stock path as a whole, read Private label vs. custom formulation: which one fits your business?, which compares the two paths on speed, cost, control, and minimums. That comparison helps a founder judge whether custom development is the right path at all, before judging any individual development fee. If custom work is the right path, the fee should be judged as the price of reaching a formula worth producing — chemist time, trial materials, and revision rounds, billed separately from production, with its scope confirmed in writing. Judged that way, a development fee stops looking mysterious and starts looking like what it is: the funded first stage of a custom launch.